MorphoSys US Inc.

MorphoSys US Inc. is a wholly owned subsidiary of MorphoSys AG established with the goal to build commercial capabilities in the U.S.

MorphoSys US Inc. Management

Jennifer Herron

President of MorphoSys US Inc., Executive Vice President, Global Commercial

Biography

Jennifer Herron

President of MorphoSys US Inc., Executive Vice President, Global Commercial

Year of Birth 1970
Nationality US-American
Place of residence Terrace Skillman, NJ, USA
Management Member of MorphoSys US Inc. since 2018
End of appointment 2020

Jennifer L. Herron joined MorphoSys as President, MorphoSys US Inc. and Executive Vice President, Global Commercial in July 2018.
Before joining MorphoSys, Ms. Herron served 27 years in leadership positions of growing responsibility in general management, commercial and marketing in the global pharmaceutical industry, specifically in oncology. She joins MorphoSys after her previous role as Executive Vice President and Chief Commercial Officer at ARIAD Pharmaceuticals (today: Takeda). Prior to this, she worked ten years for Bristol-Myers Squibb (BMS). Before that, Ms. Herron worked in various marketing roles in oncology for Novartis and GSK. Ms. Herron started her career as a clinical research associate at Boehringer Mannheim Pharmaceuticals (today: Roche).
Ms. Herron earned a Bachelor of Arts in Biology and Economics from Lehigh University, Pennsylvania, and an MBA from Georgetown University, Washington D.C. Ms. Herron completed the Harvard Business School Executive Education program on Corporate Directorship and the Graduate Management Program at Oxford University.
 

 

Further Information

MorphoSys Corporate Releases

See all